Nat Neurosci. 2007 Janairu;10(1):93-9. Epub 2006 Disamba 3.
Russo SJ1, Bolanos CA, Karin BAS, DeCarolis NA, Kasuwanci W, Kumar A, Winstanley CA, Ƙaurin NE, Wiley MD, Kai DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ.
Abstract
Amfani da morphine na yau da kullun (ta hanyar pellet ɗin subcutaneous) yana rage girman ƙwayoyin dopamine a cikin yankin ventral tegmental (VTA), wani yanki mai mahimmanci na lada a cikin kwakwalwa, duk da haka ba a san tushen kwayoyin halitta da sakamakon aikin wannan tasirin ba. A cikin wannan binciken, mun yi amfani da canja wurin kwayar halitta ta hanyar kwayar cuta a cikin bera don yadda wannan raguwar morphine ta hanyar insulin receptor substrate 2 (IRS2)-thymoma viral proto-oncogene (Akt) hanyar siginar a cikin VTA ke daidaita raguwar girman ƙwayoyin dopamine da aka gani bayan fallasa morphine kuma wannan raguwar yana rage ladan morphine, kamar yadda aka auna ta hanyar fifikon wuri. Mun ƙara nuna cewa raguwar girman ƙwayoyin dopamine na VTA yana ci gaba har zuwa makonni 2 bayan janyewar morphine, wanda yayi daidai da haƙurin tasirin lada na morphine wanda ya faru sakamakon fallasa morphine na yau da kullun. Waɗannan binciken suna nuna hanyar siginar IRS2-Akt kai tsaye a matsayin mai kula da yanayin ƙwayoyin dopamine da ladan opiate.